

ManuCyte
Self-learning modular manufacturing platform for flexible, patient specific cell production
Project website
Project data
External identifier
FP7 260100
Cost
€ 3.435.700
Department in charge
ManuCyte focuses on the development of an intelligent, modular manufacturing platform for flexible, patient-specific cell production which will increase efficiency of personalised cell production in terms of quality, throughput, and costs. This objective will be reached by combining several high-sophisticated technologies such as
- a modular and scalable concept for the setup of cell production platforms, which is based on plug-ins and allows a flexible composition of functionalities, extension of capacities, as well as fast ramp up.
- a micro-fluidic component which provides cell culture medium specifically customised for each cell culture.
- bioreactors with integrated sensor technology, which are capable for highly automated processes as well as the associated incubation component
- the application of a cost-neutral cleanroom and sterilisation concept to keep cell cultures free of contaminations from the environment and between different cell cultures.
- optical and biochemical inline monitoring methodologies, which enable the evaluation of cell status within the production process
- a MES (Manufacturing Execution System) with LIMS (Laboratory Information and Management System) functionalities
- a self-learning knowledge-based cell behaviour model and advanced cell process control functionalities.
Participants
- ÅBO AKADEMI University
- acp-IT AG
- AFT GmbH
- Chip-Man Technologies Oy
- Fraunhofer IPA (project leader)
- mta automation ag
- MTA SZTAKI
- PRIMACYT GmbH
- Regensburg University of Applied Sciences
Manager
Members
